Residual urine in an elderly female population: novel implications for oral @entity172 replacement and impact on recurrent XXXX .

@entity1 @entity172 @entity6 @entity41 @entity293
PURPOSE: While the distribution of @entity41 ( @entity41 ) has been well studied in @entity1 , scant literature is available concerning @entity41 in @entity1 . We characterized any relationship between @entity41 and @entity293 ( @entity293 ). We also characterized other factors that could impact bladder emptying, including oral @entity172 replacement therapy. MATERIALS AND METHODS: Inclusion criteria were at least 2 clinic visits and no antimicrobial prophylaxis in the last year. @entity1 with a history of @entity6 or cystocele were excluded. In a 17-month period 204 @entity1 met inclusion criteria. @entity41 was measured by catheterized specimen. @entity1 were categorized into groups by @entity293 history, namely 94 of those with no UTIs in the last year (group 1) and 110 with 1 or more documented UTIs in the last year (group 2). Factors that could affect bladder emptying were tested for the impact on @entity41 . RESULTS: Mean @entity41 in the study group was 53.13 ml. The mean @entity41 in groups 1 and 2 was 33 and 70.25 ml, respectively. The difference between these 2 groups was significant (p <0.0001). @entity172 status data were available on 186 @entity1 . The 62 @entity1 on @entity172 replacement therapy had a mean @entity41 of 39.33 ml. The 124 @entity1 not on @entity172 replacement therapy had a mean @entity41 of 66.67 ml. The difference between these 2 groups was significant (p = 0.002) and independent of @entity293 history. CONCLUSIONS: Of elderly @entity1 those with high @entity41 were more likely to have recurrent UTIs. Improved bladder function was documented in @entity1 receiving oral @entity172 replacement therapy.
